As of 2025-12-25, the EV/EBITDA ratio of Inhibrx Inc (INBX) is -10.26. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INBX's latest enterprise value is 1,115.26 mil USD. INBX's TTM EBITDA according to its financial statements is -108.75 mil USD. Dividing these 2 quantities gives us the above INBX EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 15.5x | 15.3x |
| Forward P/E multiples | 19.8x - 35.7x | 22.2x |
| Fair Price | (103.30) - 4,410.65 | 1,317.45 |
| Upside | -228.5% - 5388.6% | 1539.4% |
| Date | EV/EBITDA |
| 2025-12-24 | -10.15 |
| 2025-12-23 | -9.95 |
| 2025-12-22 | -11.21 |
| 2025-12-19 | -11.03 |
| 2025-12-18 | -10.92 |
| 2025-12-17 | -10.62 |
| 2025-12-16 | -10.42 |
| 2025-12-15 | -9.70 |
| 2025-12-12 | -10.15 |
| 2025-12-11 | -10.50 |
| 2025-12-10 | -10.81 |
| 2025-12-09 | -11.40 |
| 2025-12-08 | -12.01 |
| 2025-12-05 | -11.47 |
| 2025-12-04 | -11.20 |
| 2025-12-03 | -10.60 |
| 2025-12-02 | -10.51 |
| 2025-12-01 | -10.31 |
| 2025-11-28 | -10.76 |
| 2025-11-26 | -10.70 |
| 2025-11-25 | -10.57 |
| 2025-11-24 | -10.34 |
| 2025-11-21 | -10.73 |
| 2025-11-20 | -10.19 |
| 2025-11-19 | -10.49 |
| 2025-11-18 | -9.88 |
| 2025-11-17 | -9.85 |
| 2025-11-14 | -10.09 |
| 2025-11-13 | -9.49 |
| 2025-11-12 | -9.31 |
| 2025-11-11 | -9.92 |
| 2025-11-10 | -10.07 |
| 2025-11-07 | -10.30 |
| 2025-11-06 | -10.34 |
| 2025-11-05 | -10.51 |
| 2025-11-04 | -10.47 |
| 2025-11-03 | -10.40 |
| 2025-10-31 | -10.43 |
| 2025-10-30 | -10.01 |
| 2025-10-29 | -9.81 |
| 2025-10-28 | -8.67 |
| 2025-10-27 | -7.38 |
| 2025-10-24 | -7.17 |
| 2025-10-23 | -3.30 |
| 2025-10-22 | -3.73 |
| 2025-10-21 | -4.53 |
| 2025-10-20 | -4.62 |
| 2025-10-17 | -4.49 |
| 2025-10-16 | -4.40 |
| 2025-10-15 | -4.32 |